Epizyme Reports First Quarter 2018 Financial Results and Provides Business Updates
Enrollment of Patients Completed in Multiple Tazemetostat Combination Studies EU Orphan Designations Received for Tazemetostat Conference Call to be Held on May 17, 2018 at 9:30 a.m. ET CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. ( …